The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic.
 
Girish S. Kulkarni
No Relationships to Disclose
 
Thomas Hermanns
No Relationships to Disclose
 
Yanliang Wei
No Relationships to Disclose
 
Bimal Bhindi
No Relationships to Disclose
 
Raj Satkunasivam
No Relationships to Disclose
 
Peter Bostrom
No Relationships to Disclose
 
Cynthia Kuk
No Relationships to Disclose
 
Kathy Li
No Relationships to Disclose
 
Annette Erlich
No Relationships to Disclose
 
Arnoud J. Templeton
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
 
Srikala S. Sridhar
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Research Funding - Sanofi (Inst)
 
Theodorus van der Kwast
No Relationships to Disclose
 
Peter W. M. Chung
Honoraria - Abbvie
Research Funding - Sanofi
 
Robert G. Bristow
Research Funding - GenomeDx
 
Michael F. Milosevic
No Relationships to Disclose
 
Padraig Richard Warde
No Relationships to Disclose
 
Neil Eric Fleshner
Honoraria - Amgen; Bayer; Janssen
Research Funding - Amgen (Inst); Astellas Medivation (Inst); Bavarian Nordic (Inst); Bayer (Inst); Ferring (Inst); Janssen (Inst); Medivation (Inst); Nucleix (Inst); Progenics (Inst); Sanofi (Inst); Spectracure (Inst)
 
Michael A.S. Jewett
Employment - Impact Genetics (I)
Leadership - Impact Genetics (I)
Stock and Other Ownership Interests - Impact Genetics (I)
Honoraria - Janssen Oncology; Myriad Genetics; Pfizer
Consulting or Advisory Role - Theralase
Research Funding - Olympus Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Patent application filed for a new RFA device
 
Shaheena Bashir
No Relationships to Disclose
 
Alexandre Zlotta
Stock and Other Ownership Interests - iTP Biomedica
Consulting or Advisory Role - BioSyent; Ferring; Sanofi
Research Funding - Ferring (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - iTP Biomedica (Inst)